All Records
Please note that some BV estimates may be based on the results of single or few studies. You can access the background data by clicking on the ID for the measurand in question.
| ID | Measurand | BV Estimate | median CV estimate | lower CI limit | higher CI limit | Tools | |
|---|---|---|---|---|---|---|---|
| 1163 | 25-hydroxy vitamin D3 | Serum/plasma |
Within-subject
|
11.6
|
11.3 | 12.1 | |
| 1164 | 25-hydroxy vitamin D3 | Serum/plasma |
Between-subject
|
38.3
|
37.9 | 40.3 | |
| 1021 | Adiponectin | Serum/plasma |
Within-subject
|
18.8
|
14.6 | 25.6 | |
| 1022 | Adiponectin | Serum/plasma |
Between-subject
|
51.2
|
35.0 | 90.9 | |
| 933 | Alanine transaminase (ALT) | Serum/plasma |
Within-subject
|
10.1
|
9.5 | 15.6 | |
| 934 | Alanine transaminase (ALT) | Serum/plasma |
Between-subject
|
29.2
|
27.7 | 38.4 | |
| 983 | Albumin | Serum/plasma |
Within-subject
|
2.5
|
2.2 | 3.9 | |
| 984 | Albumin | Serum/plasma |
Between-subject
|
5.1
|
2.2 | 6.3 | |
| 961 | Aldosterone | Serum/plasma |
Within-subject
|
36.6
|
32.2 | 42.3 | |
| 962 | Aldosterone | Serum/plasma |
Between-subject
|
34.7
|
25.5 | 49.3 | |
| 1029 | Alkaline phosphatase (ALP) bone isoenzyme | Serum/plasma |
Within-subject
|
6.6
|
5.1 | 9.0 | |
| 1030 | Alkaline phosphatase (ALP) bone isoenzyme | Serum/plasma |
Between-subject
|
35.6
|
0.0 | 62.7 | |
| 1001 | Alkaline phosphatase (ALP), liver type | Serum/plasma |
Within-subject
|
5.4
|
4.5 | 6.0 | |
| 1002 | Alkaline phosphatase (ALP), liver type | Serum/plasma |
Between-subject
|
23.8
|
19.9 | 24.8 | |
| 949 | Alphafetoprotein | Serum/plasma |
Within-subject
|
26.7
|
23.8 | 30.3 | |
| 950 | Alphafetoprotein | Serum/plasma |
Between-subject
|
43.7
|
35.4 | 55.9 | |
| 937 | Amylase | Serum/plasma |
Within-subject
|
6.6
|
6.2 | 7.1 | |
| 938 | Amylase | Serum/plasma |
Between-subject
|
30.2
|
25.7 | 36.9 | |
| 1015 | Antimullerian hormone | Serum/plasma |
Within-subject
|
19.2
|
17.3 | 21.5 | |
| 1016 | Antimullerian hormone | Serum/plasma |
Between-subject
|
20.4
|
16.0 | 27.1 | |
| 967 | Apolipoprotein A1 | Serum/plasma |
Within-subject
|
4.7
|
3.6 | 10.4 | |
| 968 | Apolipoprotein A1 | Serum/plasma |
Between-subject
|
11.2
|
8.0 | 15.9 | |
| 987 | Apolipoprotein B | Serum/plasma |
Within-subject
|
7.7
|
4.2 | 13.5 | |
| 988 | Apolipoprotein B | Serum/plasma |
Between-subject
|
20.2
|
10.7 | 27.2 | |
| 909 | Aspartate transaminase (AST) | Serum/plasma |
Within-subject
|
9.8
|
9.4 | 13.5 | |
| 910 | Aspartate transaminase (AST) | Serum/plasma |
Between-subject
|
20.4
|
19.8 | 23.8 | |
| 1019 | b-2 microglobulin | Serum/plasma |
Within-subject
|
4.1
|
4.0 | 5.9 | |
| 1020 | b-2 microglobulin | Serum/plasma |
Between-subject
|
11.5
|
11.2 | 15.5 | |
| 1093 | Basophils | Whole Blood |
Within-subject
|
11.3
|
11.3 | 11.4 | |
| 1094 | Basophils | Whole Blood |
Between-subject
|
25.1
|
22.1 | 29.9 | |
| 1027 | Cancer antigen 125 (CA-125) | Serum/plasma |
Within-subject
|
13.3
|
9.1 | 23.3 | |
| 1028 | Cancer antigen 125 (CA-125) | Serum/plasma |
Between-subject
|
15.8
|
10.6 | 70.6 | |
| 1023 | Cancer antigen 19-9 (CA 19-9) | Serum/plasma |
Within-subject
|
22.5
|
15.8 | 27.2 | |
| 1024 | Cancer antigen 19-9 (CA 19-9) | Serum/plasma |
Between-subject
|
74.0
|
64.2 | 102.2 | |
| 1025 | Cancer antigen 72-4 (CA 72-4) | Serum/plasma |
Within-subject
|
50.3
|
43.5 | 59.5 | |
| 1026 | Cancer antigen 72-4 (CA 72-4) | Serum/plasma |
Between-subject
|
103.4
|
77.7 | 151.1 | |
| 941 | Carcinoembryonic antigen (CEA) | Serum/plasma |
Within-subject
|
17.9
|
12.6 | 30.9 | |
| 942 | Carcinoembryonic antigen (CEA) | Serum/plasma |
Between-subject
|
45.3
|
37.1 | 58.3 | |
| 981 | Chloride | Serum/plasma |
Within-subject
|
1.0
|
0.9 | 2.1 | |
| 982 | Chloride | Serum/plasma |
Between-subject
|
1.3
|
0.8 | 1.4 | |
| 927 | Cholesterol | Serum/plasma |
Within-subject
|
5.3
|
5.0 | 6.6 | |
| 928 | Cholesterol | Serum/plasma |
Between-subject
|
17.3
|
13.9 | 17.5 | |
| 947 | Chromogranin A | Serum/plasma |
Within-subject
|
14.8
|
12.8 | 16.3 | |
| 948 | Chromogranin A | Serum/plasma |
Between-subject
|
30.7
|
26.3 | 33.5 | |
| 1161 | Complement 3 (C3) | Serum/plasma |
Within-subject
|
4.6
|
4.4 | 4.9 | |
| 1162 | Complement 3 (C3) | Serum/plasma |
Between-subject
|
15.2
|
13.2 | 17.9 | |
| 957 | Cortisol | Serum/plasma |
Within-subject
|
24.0
|
21.7 | 30.9 | |
| 958 | Cortisol | Serum/plasma |
Between-subject
|
43.4
|
31.3 | 53.1 | |
| 1191 | C-reactive protein (CRP) | Serum/plasma |
Within-subject
|
33.5
|
29.4 | 63.0 | |
| 1192 | C-reactive protein (CRP) | Serum/plasma |
Between-subject
|
87.7
|
76.3 | 94.0 | |
| 1193 | C-reactive protein (CRP) - high-sensitive | Serum/plasma |
Within-subject
|
58.9
|
53.2 | 66.0 | |
| 1195 | C-reactive protein (CRP) - high-sensitive | Serum/plasma |
Between-subject
|
77.4
|
56.0 | 121.5 | |
| 935 | Creatine Kinase | Serum/plasma |
Within-subject
|
15.4
|
14.5 | 16.5 | |
| 936 | Creatine Kinase | Serum/plasma |
Between-subject
|
31.8
|
25.7 | 41.5 | |
| 971 | Creatinine | Serum/plasma |
Within-subject
|
4.4
|
4.1 | 8.5 | |
| 972 | Creatinine | Serum/plasma |
Between-subject
|
14.3
|
7.0 | 17.4 | |
| 995 | Cystatin C | Serum/plasma |
Within-subject
|
4.0
|
3.9 | 8.6 | |
| 996 | Cystatin C | Serum/plasma |
Between-subject
|
12.1
|
12.0 | 15.1 | |
| 917 | Dehydroepiandrosterone sulphate (DHEAS) | Serum/plasma |
Within-subject
|
6.0
|
1.5 | 8.1 | |
| 918 | Dehydroepiandrosterone sulphate (DHEAS) | Serum/plasma |
Between-subject
|
21.0
|
14.7 | 35.9 | |
| 1063 | Eosinophils | Whole Blood |
Within-subject
|
12.3
|
10.1 | 14.8 | |
| 1064 | Eosinophils | Whole Blood |
Between-subject
|
64.1
|
59.9 | 70.5 | |
| 1081 | Erythrocytes | Whole Blood |
Within-subject
|
2.4
|
1.8 | 4.0 | |
| 1082 | Erythrocytes | Whole Blood |
Between-subject
|
6.5
|
6.1 | 7.4 | |
| 925 | Estradiol | Serum/plasma |
Within-subject
|
14.6
|
12.7 | 15.0 | |
| 926 | Estradiol | Serum/plasma |
Between-subject
|
13.6
|
13.0 | 15.0 | |
| 1197 | Ferritin | Serum/plasma |
Within-subject
|
17.3
|
12.8 | 21.8 | |
| 1057 | Fibroblast growth factor-23 | Serum/plasma |
Within-subject
|
14.2
|
12.3 | 16.8 | |
| 1058 | Fibroblast growth factor-23 | Serum/plasma |
Between-subject
|
13.4
|
9.0 | 22.1 | |
| 963 | Follicle stimulating hormone (FSH) | Serum/plasma |
Within-subject
|
11.6
|
8.0 | 17.3 | |
| 964 | Follicle stimulating hormone (FSH) | Serum/plasma |
Between-subject
|
46.4
|
36.0 | 49.0 | |
| 1045 | Free lambda light chain | Serum/plasma |
Within-subject
|
4.8
|
4.2 | 5.6 | |
| 1011 | Fructosamine | Serum/plasma |
Within-subject
|
2.3
|
1.6 | 3.1 | |
| 1012 | Fructosamine | Serum/plasma |
Between-subject
|
6.3
|
4.7 | 9.4 | |
| 915 | g-glutamyl transferase activity | Serum/plasma |
Within-subject
|
8.6
|
7.4 | 12.0 | |
| 916 | g-glutamyl transferase activity | Serum/plasma |
Between-subject
|
41.3
|
30.9 | 41.8 | |
| 997 | Glucose | Serum/plasma |
Within-subject
|
4.8
|
3.4 | 12.1 | |
| 998 | Glucose | Serum/plasma |
Between-subject
|
7.5
|
2.7 | 10.8 | |
| 1077 | Haematocrit (Hct) | Whole Blood |
Within-subject
|
2.7
|
2.1 | 3.1 | |
| 1078 | Haematocrit (Hct) | Whole Blood |
Between-subject
|
5.4
|
4.6 | 6.5 | |
| 1059 | Haemoglobin A1c (HbA1c) | Whole Blood |
Within-subject
|
1.3
|
1.2 | 2.5 | |
| 1060 | Haemoglobin A1c (HbA1c) | Whole Blood |
Between-subject
|
6.1
|
3.3 | 20.2 | |
| 1065 | Haemoglobin (Hb) | Whole Blood |
Within-subject
|
2.7
|
1.7 | 3.6 | |
| 1066 | Haemoglobin (Hb) | Whole Blood |
Between-subject
|
5.9
|
3.2 | 7.0 | |
| 1169 | Haptoglobin | Serum/plasma |
Within-subject
|
8.6
|
7.4 | 25.7 | |
| 1170 | Haptoglobin | Serum/plasma |
Between-subject
|
39.0
|
28.8 | 39.4 | |
| 919 | HDL cholesterol | Serum/plasma |
Within-subject
|
5.7
|
4.7 | 23.0 | |
| 920 | HDL cholesterol | Serum/plasma |
Between-subject
|
24.7
|
18.4 | 51.4 | |
| 911 | Human epididymis protein 4 (HE4) | Serum/plasma |
Within-subject
|
9.7
|
8.4 | 11.4 | |
| 912 | Human epididymis protein 4 (HE4) | Serum/plasma |
Between-subject
|
16.4
|
12.7 | 22.6 | |
| 1041 | Immunoglobulin A (IgA) | Serum/plasma |
Within-subject
|
5.7
|
5.0 | 6.7 | |
| 1042 | Immunoglobulin A (IgA) | Serum/plasma |
Between-subject
|
19.6
|
13.0 | 35.0 | |
| 1043 | Immunoglobulin G (IgG) | Serum/plasma |
Within-subject
|
3.5
|
3.0 | 4.4 | |
| 1044 | Immunoglobulin G (IgG) | Serum/plasma |
Between-subject
|
17.1
|
13.0 | 22.0 | |
| 1039 | Immunoglobulin M (IgM) | Serum/plasma |
Within-subject
|
5.9
|
5.1 | 6.9 | |
| 1040 | Immunoglobulin M (IgM) | Serum/plasma |
Between-subject
|
48.5
|
34.8 | 80.1 | |
| 1009 | Insulin | Serum/plasma |
Within-subject
|
27.5
|
21.1 | 27.9 | |
| 1010 | Insulin | Serum/plasma |
Between-subject
|
19.5
|
4.3 | 45.4 | |
| 1003 | Insulin-like GF-1 | Serum/plasma |
Within-subject
|
9.4
|
7.9 | 11.7 | |
| 1004 | Insulin-like GF-1 | Serum/plasma |
Between-subject
|
27.0
|
18.7 | 47.7 | |
| 999 | Lactate dehydrogenase activity | Serum/plasma |
Within-subject
|
5.2
|
4.9 | 5.6 | |
| 1000 | Lactate dehydrogenase activity | Serum/plasma |
Between-subject
|
12.5
|
10.8 | 14.7 | |
| 921 | LDL Cholesterol | Serum/plasma |
Within-subject
|
8.4
|
5.4 | 13.7 | |
| 922 | LDL Cholesterol | Serum/plasma |
Between-subject
|
26.1
|
17.8 | 37.7 | |
| 1091 | Leukocytes | Whole Blood |
Within-subject
|
10.2
|
9.8 | 11.4 | |
| 1092 | Leukocytes | Whole Blood |
Between-subject
|
17.2
|
15.8 | 21.2 | |
| 943 | Lipase | Serum/plasma |
Within-subject
|
9.2
|
7.7 | 41.1 | |
| 944 | Lipase | Serum/plasma |
Between-subject
|
24.8
|
23.1 | 37.6 | |
| 989 | Lipoprotein (a) | Serum/plasma |
Within-subject
|
7.6
|
5.1 | 10.6 | |
| 990 | Lipoprotein (a) | Serum/plasma |
Between-subject
|
135.8
|
94.8 | 238.4 | |
| 913 | Luteinising hormone (LH) | Serum/plasma |
Within-subject
|
23.1
|
22.0 | 25.9 | |
| 914 | Luteinising hormone (LH) | Serum/plasma |
Between-subject
|
27.7
|
20.8 | 37.0 | |
| 1071 | Lymphocytes | Whole Blood |
Within-subject
|
10.1
|
9.5 | 12.3 | |
| 1072 | Lymphocytes | Whole Blood |
Between-subject
|
23.7
|
21.3 | 24.6 | |
| 1095 | Mean corpuscular haemoglobin concentration (MCHC) | Whole Blood |
Within-subject
|
0.9
|
0.6 | 1.8 | |
| 1096 | Mean corpuscular haemoglobin concentration (MCHC) | Whole Blood |
Between-subject
|
1.3
|
0.9 | 1.6 | |
| 1079 | Mean corpuscular haemoglobin (MCH) | Whole Blood |
Within-subject
|
0.6
|
0.2 | 1.7 | |
| 1080 | Mean corpuscular haemoglobin (MCH) | Whole Blood |
Between-subject
|
4.6
|
4.3 | 5.5 | |
| 1097 | Mean corpuscular volume (MCV) | Whole Blood |
Within-subject
|
1.7
|
1.5 | 1.9 | |
| 1098 | Mean corpuscular volume (MCV) | Whole Blood |
Between-subject
|
5.0
|
4.2 | 6.1 | |
| 1073 | Mean platelet volume (MPV) | Whole Blood |
Within-subject
|
1.9
|
1.6 | 2.2 | |
| 1074 | Mean platelet volume (MPV) | Whole Blood |
Between-subject
|
6.4
|
5.7 | 7.0 | |
| 1069 | Monocytes | Whole Blood |
Within-subject
|
11.4
|
11.1 | 11.8 | |
| 1070 | Monocytes | Whole Blood |
Between-subject
|
16.3
|
15.9 | 17.0 | |
| 955 | Neuron specific enolase | Serum/plasma |
Within-subject
|
10.9
|
10.1 | 21.5 | |
| 956 | Neuron specific enolase | Serum/plasma |
Between-subject
|
16.6
|
11.5 | 28.8 | |
| 1099 | Neutrophils | Whole Blood |
Within-subject
|
13.6
|
11.8 | 16.0 | |
| 1100 | Neutrophils | Whole Blood |
Between-subject
|
20.7
|
15.4 | 30.2 | |
| 1183 | Orosmucoid | Serum/plasma |
Within-subject
|
7.4
|
6.8 | 19.3 | |
| 1184 | Orosmucoid | Serum/plasma |
Between-subject
|
24.1
|
24.0 | 24.9 | |
| 1031 | Osteocalcin | Serum/plasma |
Within-subject
|
7.8
|
5.4 | 9.1 | |
| 1032 | Osteocalcin | Serum/plasma |
Between-subject
|
24.5
|
20.5 | 30.9 | |
| 939 | Pancreatic Amylase | Serum/plasma |
Within-subject
|
6.7
|
6.3 | 9.3 | |
| 940 | Pancreatic Amylase | Serum/plasma |
Between-subject
|
25.7
|
24.9 | 31.7 | |
| 1007 | Parathyroid hormone | Serum/plasma |
Within-subject
|
24.4
|
20.2 | 25.9 | |
| 1008 | Parathyroid hormone | Serum/plasma |
Between-subject
|
23.5
|
21.8 | 43.4 | |
| 1067 | Plateletcrit | Whole Blood |
Within-subject
|
4.9
|
4.2 | 5.9 | |
| 1068 | Plateletcrit | Whole Blood |
Between-subject
|
14.1
|
10.7 | 20.2 | |
| 1075 | Platelet distribution wide (PDW) | Whole Blood |
Within-subject
|
3.4
|
3.1 | 3.7 | |
| 1076 | Platelet distribution wide (PDW) | Whole Blood |
Between-subject
|
13.5
|
11.9 | 15.9 | |
| 1089 | Platelet larger cell ratio (P-LCR) | Whole Blood |
Within-subject
|
4.8
|
4.0 | 5.8 | |
| 1090 | Platelet larger cell ratio (P-LCR) | Whole Blood |
Between-subject
|
19.8
|
15.2 | 28.3 | |
| 979 | Potassium | Serum/plasma |
Within-subject
|
4.1
|
3.1 | 5.4 | |
| 980 | Potassium | Serum/plasma |
Between-subject
|
4.2
|
4.1 | 7.7 | |
| 965 | Prolactin | Serum/plasma |
Within-subject
|
19.9
|
17.1 | 23.6 | |
| 966 | Prolactin | Serum/plasma |
Between-subject
|
27.0
|
18.4 | 46.8 | |
| 1033 | Prostate specific antigen (PSA) | Serum/plasma |
Within-subject
|
6.8
|
6.2 | 7.5 | |
| 1034 | Prostate specific antigen (PSA) | Serum/plasma |
Between-subject
|
42.0
|
34.0 | 54.8 | |
| 1037 | Prostate specific antigen (PSA) - Conjugated | Serum/plasma |
Within-subject
|
8.8
|
8.0 | 9.7 | |
| 1038 | Prostate specific antigen (PSA) - Conjugated | Serum/plasma |
Between-subject
|
57.7
|
46.6 | 75.6 | |
| 953 | Prostate specific antigen (PSA) - free | Serum/plasma |
Within-subject
|
7.1
|
6.5 | 7.7 | |
| 954 | Prostate specific antigen (PSA) - free | Serum/plasma |
Between-subject
|
46.2
|
37.4 | 60.3 | |
| 977 | Protein (total) | Serum/plasma |
Within-subject
|
2.6
|
1.6 | 5.1 | |
| 978 | Protein (total) | Serum/plasma |
Between-subject
|
4.6
|
2.8 | 5.7 | |
| 1083 | Red cell distribution wide standard deviation (RDW-SD) | Whole Blood |
Within-subject
|
1.2
|
0.9 | 1.6 | |
| 1084 | Red cell distribution wide standard deviation (RDW-SD) | Whole Blood |
Between-subject
|
6.6
|
4.6 | 11.9 | |
| 1049 | Renin | Serum/plasma |
Within-subject
|
30.1
|
26.6 | 34.7 | |
| 1050 | Renin | Serum/plasma |
Between-subject
|
41.6
|
31.9 | 57.6 | |
| 1085 | Reticulocyte haemoglobin equivalent (RET-He) | Whole Blood |
Within-subject
|
1.8
|
0.7 | 3.4 | |
| 1086 | Reticulocyte haemoglobin equivalent (RET-He) | Whole Blood |
Between-subject
|
3.4
|
2.7 | 4.1 | |
| 1087 | Reticulocytes | Whole Blood |
Within-subject
|
9.7
|
6.4 | 11.0 | |
| 1088 | Reticulocytes | Whole Blood |
Between-subject
|
27.1
|
22.1 | 30.5 | |
| 993 | S100B | Serum/plasma |
Within-subject
|
10.2
|
9.7 | 10.7 | |
| 994 | S100B | Serum/plasma |
Between-subject
|
32.7
|
28.5 | 38.3 | |
| 975 | Sexual-hormone-binding-globulin (SHBG) | Serum/plasma |
Within-subject
|
9.7
|
4.3 | 14.0 | |
| 976 | Sexual-hormone-binding-globulin (SHBG) | Serum/plasma |
Between-subject
|
35.6
|
30.0 | 94.7 | |
| 973 | Sodium | Serum/plasma |
Within-subject
|
0.5
|
0.2 | 1.4 | |
| 974 | Sodium | Serum/plasma |
Between-subject
|
1.2
|
0.5 | 1.4 | |
| 1055 | Suppression of tumorigenicity 2 (ST2) | Serum/plasma |
Within-subject
|
10.5
|
9.1 | 12.2 | |
| 1056 | Suppression of tumorigenicity 2 (ST2) | Serum/plasma |
Between-subject
|
30.4
|
23.9 | 41.3 | |
| 1005 | Tartrate-resistant acid phosphatase (TRAP) | Serum/plasma |
Within-subject
|
10.8
|
8.1 | 15.0 | |
| 1006 | Tartrate-resistant acid phosphatase (TRAP) | Serum/plasma |
Between-subject
|
13.3
|
0.0 | 24.8 | |
| 959 | Testosterone | Serum/plasma |
Within-subject
|
11.9
|
9.3 | 15.1 | |
| 960 | Testosterone | Serum/plasma |
Between-subject
|
17.9
|
16.5 | 83.4 | |
| 991 | Testosterone - free | Serum/plasma |
Within-subject
|
22.0
|
17.5 | 26.4 | |
| 992 | Testosterone - free | Serum/plasma |
Between-subject
|
29.0
|
19.4 | 50.7 | |
| 1061 | Thrombocytes | Whole Blood |
Within-subject
|
5.9
|
4.5 | 10.0 | |
| 1062 | Thrombocytes | Whole Blood |
Between-subject
|
19.4
|
16.4 | 27.3 | |
| 931 | Thyroglobulin | Serum/plasma |
Within-subject
|
12.8
|
10.0 | 17.1 | |
| 932 | Thyroglobulin | Serum/plasma |
Between-subject
|
29.2
|
17.8 | 72.3 | |
| 945 | Thyroid stimulating hormone (TSH) | Serum/plasma |
Within-subject
|
15.9
|
14.8 | 25.1 | |
| 946 | Thyroid stimulating hormone (TSH) | Serum/plasma |
Between-subject
|
31.9
|
24.0 | 36.9 | |
| 951 | Thyroxine - free (FT4) | Serum/plasma |
Within-subject
|
7.7
|
4.8 | 9.5 | |
| 952 | Thyroxine - free (FT4) | Serum/plasma |
Between-subject
|
12.0
|
11.7 | 12.1 | |
| 1013 | Tissue plasminogen activator (TPA) | Serum/plasma |
Within-subject
|
27.1
|
25.1 | 29.2 | |
| 1014 | Tissue plasminogen activator (TPA) | Serum/plasma |
Between-subject
|
62.4
|
49.8 | 83.2 | |
| 969 | Total tri-iodothyronine (T3) | Serum/plasma |
Within-subject
|
9.2
|
6.9 | 10.4 | |
| 970 | Total tri-iodothyronine (T3) | Serum/plasma |
Between-subject
|
11.9
|
4.4 | 20.4 | |
| 1187 | Transferrin | Serum/plasma |
Within-subject
|
3.4
|
3.2 | 3.6 | |
| 1188 | Transferrin | Serum/plasma |
Between-subject
|
13.9
|
12.1 | 16.4 | |
| 1173 | Transthyretin | Serum/plasma |
Within-subject
|
10.9
|
9.8 | 12.2 | |
| 1174 | Transthyretin | Serum/plasma |
Between-subject
|
19.1
|
14.3 | 28.1 | |
| 929 | Triglycerides | Serum/plasma |
Within-subject
|
19.7
|
17.7 | 21.7 | |
| 930 | Triglycerides | Serum/plasma |
Between-subject
|
35.8
|
23.1 | 41.2 | |
| 1017 | Triiodothyronine - free (FT3) | Serum/plasma |
Within-subject
|
6.0
|
4.7 | 7.9 | |
| 1018 | Triiodothyronine - free (FT3) | Serum/plasma |
Between-subject
|
16.5
|
12.7 | 22.5 | |
| 1035 | Tyrosine | Serum/plasma |
Within-subject
|
7.5
|
4.5 | 10.3 | |
| 1036 | Tyrosine | Serum/plasma |
Between-subject
|
11.9
|
8.2 | 19.5 | |
| 923 | Tyroxine - total (T4) | Serum/plasma |
Within-subject
|
6.4
|
4.9 | 7.4 | |
| 924 | Tyroxine - total (T4) | Serum/plasma |
Between-subject
|
12.0
|
11.0 | 12.2 | |
| 985 | Urea | Serum/plasma |
Within-subject
|
14.1
|
9.5 | 14.4 | |
| 986 | Urea | Serum/plasma |
Between-subject
|
20.3
|
1.1 | 22.5 | |
© 2018 - 2019
This website and its content is copyright of EFLM. All rights reserved.
Any redistribution or reproduction of part or all of the contents in any form is prohibited other than the following:
you may print or download to a local hard disk extracts for your personal and non-commercial use only
you may copy the content to individual third parties for their personal use, but only if you acknowledge the website as the source of the material
You may not, except with our express written permission, distribute or commercially exploit the content. Nor may you transmit it or store it in any other website or other form of electronic retrieval system.
European Federation of Clinical Chemistry and Laboratory Medicine
Ms Silvia Cattaneo
Via Carlo Farini 81
20159 Milano - Italy
biologicalvariationdatabase@eflm.eu
European Federation of Clinical Chemistry and Laboratory Medicine
Ms Silvia Cattaneo
Via Carlo Farini 81
20159 Milano - Italy
biologicalvariationdatabase@eflm.eu